Ronald Hao Xi sold 1 million shares of INNOVENT BIO (01801) at approximately HK$85 per share.

19:22 04/04/2026

On March 30th, Ede Ronald Hao Xi reduced his holding of Sino Biopharmaceutical (01801) by 1 million shares, with a price of 85.0005 Hong Kong dollars per share, totaling 85 million Hong Kong dollars.

The latest information from the Hong Kong Stock Exchange shows that on March 30, Ede Ronald Hao Xi reduced his holdings of INNOVENT BIO (01801) by 1 million shares, with a price of 85.0005 Hong Kong dollars per share, for a total amount of 85.005 million Hong Kong dollars. After the reduction, the latest number of shares held is approximately 7.332 million shares, and the latest shareholding ratio is 0.42%.

Chairman Zheng Jiachun increased his holding of CHOW TAI FOOK (01929) by 30,000 shares at a price of approximately HK$10.76 per share.

Chairman Pan Binze increases his holdings in TEXWINCA HOLD (00321) by 2.76 million shares at a price of approximately 1.21 Hong Kong dollars per share.

CICC: Maintain "Buy" rating on HANSOH PHARMA (03692), raise target price to HK$46.41

Chairman Zheng Jiachun increased his holding of CHOW TAI FOOK (01929) by 30,000 shares at a price of approximately HK$10.76 per share.

Chairman Pan Binze increases his holdings in TEXWINCA HOLD (00321) by 2.76 million shares at a price of approximately 1.21 Hong Kong dollars per share.

CICC: Maintain "Buy" rating on HANSOH PHARMA (03692), raise target price to HK$46.41